India: India - FSSAI Publishes Approved List of Specialty Products for Inborn - Congenital - Errors of Metabolism Conditions

  |   Attaché Report (GAIN)   |   IN2022-0022

On February 22, 2022, India’s Ministry of Health and Family Welfare/Food Safety and Standards Authority of India (FSSAI) published Stds/SP-05/Orders/FSSAI (E1317). The order includes a list of conditions associated with inborn (congenital) errors of metabolism (IEM) along with the specialty food products that can be manufactured, sold, marketed, or imported to address these imbalances. The FSSAI implementation date for the approved list is April 1, 2022. Until such time, the FSSAI will continue to allow the import of specialty food products listed in its earlier directive of June 30, 2021.

Related Reports

The biotechnology regulatory system in Ukraine is still not fully developed, but the country is gradually adjusting its domestic policies to align with European Union regulations.
Attaché Report (GAIN)

Tunisia: Agricultural Biotechnology Annual

Tunisia is continuing to postpone non-urgent matters in front of major political and economic reforms. As a result, Tunisia’s biosafety framework, which was drafted in 2014, remains on hold with no timeframe for a review and parliamentary vote.
Attaché Report (GAIN)

Thailand: Rice Price - Weekly

Export prices of white and parboiled rice rose one percent from the previous week as exporters reportedly continued to secure the rice supplies to fulfill contract shipments.